MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

FDA approves abraxane for breast cancer

Breast cancer treatment Breast cancer main Breast cancer news  

FDA approves abraxane for breast cancer : Information from MedicineWorld.Org
FDA approves abraxane for breast cancer
       FDA has approved Abraxane for the treatment of metastatic breast cancer. This drug is an improved version of Taxol, which is currently used for the treatment of metastatic breast cancer. This new drug is an improved version of Taxol. Abraxane is manufactured by American Pharma and is the first approval for the group of drugs called, protein-bound particle drugs. These drugs are free of toxic solvents which may cause problems with the administration of chemotherapy drugs. Abraxane, consisting only of albumin-bound paclitaxel nanoparticles, and is free of toxic solvents. Abraxane is an step forward in the treatment of breast cancer. The pivotal clinical trial that lead to the FDA approval has demonstrated that Abraxane had superior response rate when compared to Taxol in patients with metastatic breast cancer. The study consisted of 460 patients with metastatic breast cancer that showed Abraxane has a superior response rate and has almost double reconciled target lesion response rate when compared with Taxol. FDA approval for Abraxane is for those patients who had treatment failures to combination chemotherapy for metastatic breast cancer or those whos disease has relapsed within 6 months of adjuvant chemotherapy. Patients should have been previously treated with anthracyclin group of drugs (like doxorubicin or epirubicin) or should have contra-indication for these drugs before starting on Abraxane.

Read more about abraxane:
Abraxane, the new generation paclitaxel

 
 
 
Related Resources
  • Brca research
  • Brca
  • Brca1 and brca2
  • Epidemiology
  • Breast Main
  • My risk
  • Risk factors
  • Breast cancer stats
  • Symptoms
  • Bisphosphonates
  • Chemodrugs: breast
  • Chemotherapy
  • Doxorubicin
  • Hormone therapy
  • Monoclonal
  • Radiationtherapy
  • Recurrent
  • Rx by stage
  • Surgery
  • Treatment


  •  
     
    epidemiology
     Breast cancer
     Colon cancer
     Prostate cancer
     Ovarian cancer
     Esophageal cancer
     Bladder cancer
     Anal cancer
     Endometrial cancer
     Pancreatic cancer
     Cervical cancer
     Gastric cancer
     Cancer News